NattoPharma

Insiders

NattoPharma ASA  is listed on Nasdaq First North Premier (“First North”) and complies with the disclosure rules in the First North Nordic - Rulebook (including the rules applicable to companies traded on First North Premier), as applicable from time to time. In accordance with the Rulebook and the Company’s insider policy, a list of all permanent insiders and their shareholdings shall  be made available on the website. The Board of Directors has also implemented a policy stating that no person in senior management or any director of the company or any group company is permitted to make any transactions in the securities of the company within 30 days prior to and including the day of disclosure of the company’s interim reports and year-end reports.

Following members of the Board hold shares in the Company

NameTitle# of shares% of sharesOptions
Frode Marc Bohan Chairman 1,236,287 7,08% 100 000
Christopher von Schirach Director 0 0 % 50 000
Katarzyna Maresz Director 0 0% 50 000
Stefan Hallden Director 0 0% 0
Annette Elmqvist Director 0 0% 0

 

Frode Marc Bohan includes NxT Capital Ltd, which holds 200.000 shares

 

Following members of the Management hold shares in the Company.

NameTitle# of shares% of sharesOptions
Daniel Rosenbaum CEO 100,000 0.57% 75,000
Kjetil Ramsøy CFO 100,000 0.57% 37,500
Hogne Vik CMO* 556,480 3.19% 100,000
Randall Eric Andersson VP Sales & Marketing 50,000 0.29% 25,000
Rudi De Man
VP Sales Europe & Asia 30,000 0.17% 25,000
William Sommer VP Global Development and Regulatory 25,000 0.14% 25,000

 

* Hogne Vik is shareholder through Eng AS.

 

Insiders with other positions hold following shares:

NameTitle# of shares% of sharesOptions
Espen Johansen
Auditor 0 0% 0

 

Latest transactions

DateHolderTransactionSecurityAmountTotal
29/12/15 Life Science Sweden AB Purchase Share 258,949 1,878,910
26/08/15 Novel Nutrition Network Ltd, Cyprus Sale Share 300,000 3,090,000
26/08/15 Bohan & CO. AS Purchase Share 300,000 3,090,000
15/05/15 Bohan & CO AS + NxT Capital Ltd Subscription Share 324,260 4,539,640
15/05/15 Eng AS Subscription Share 357,143 5,000,002

Contact Us

NattoPharma ASA
(head office)
Lilleakerveien 2B
0283 Oslo, Norway
info@nattopharma.com
Tel: (+47) 40 00 90 08

NattoPharma USA, Inc.
(North American Subsidiary)
328 Amboy Avenue, Ste. D
Metuchen, NJ 08840, USA
info.US@nattopharma.com
Tel: (+1) 609-454-2992

NattoPharma contact information:
Main office: Lilleakerveien 2B, 0283 Oslo,Norway
North American Subsidary: 328 Amboy Ave.,Ste. D,Metuchen, NJ 08840
Tel: (+47) 40 00 90 08
Tel: (+1) 609-454-2992
E-mail: info@nattopharma.com
E-mail: info.US@nattopharma.com
Created by:
Nutricon logo.
Search term:
Newsletter